Logo image
Human Thrombomodulin Knock-In Mice Reveal Differential Effects of Human Thrombomodulin on Thrombosis and Atherosclerosis
Journal article   Open access   Peer reviewed

Human Thrombomodulin Knock-In Mice Reveal Differential Effects of Human Thrombomodulin on Thrombosis and Atherosclerosis

Thomas J RAIFE, Denis M DWYRE, Nobuyo MAEDA, Steven R LENTZ, Jeff W STEVENS, Rochelle A ERGER, Lorie LEO, Katina M WILSON, Jose A FERNANDEZ, Jennifer WILDER, …
Arteriosclerosis, thrombosis, and vascular biology, Vol.31(11), pp.2509-2517
2011
DOI: 10.1161/ATVBAHA.111.236828
PMID: 21885846
url
https://doi.org/10.1161/ATVBAHA.111.236828View
Published (Version of record) Open Access

Abstract

Objective— We sought to develop a murine model to examine the antithrombotic and antiinflammatory functions of human thrombomodulin in vivo. Methods and Results— Knock-in mice that express human thrombomodulin from the murine thrombomodulin gene locus were generated. Compared with wild-type mice, human thrombomodulin knock-in mice exhibited decreased protein C activation in the aorta (P<0.01) and lung (P<0.001). Activation of endogenous protein C following infusion of thrombin was decreased by 90% in knock-in mice compared with wild-type mice (P<0.05). Carotid artery thrombosis induced by photochemical injury occurred more rapidly in knock-in mice (12±3 minutes) than in wild-type mice (31±6 minutes; P<0.05). No differences in serum cytokine levels were detected between knock-in and wild-type mice after injection of endotoxin. When crossed with apolipoprotein E–deficient mice and fed a Western diet, knock-in mice had a further decrease in protein C activation but did not exhibit increased atherosclerosis. Conclusion— Expression of human thrombomodulin in place of murine thrombomodulin produces viable mice with a prothrombotic phenotype but unaltered responses to systemic inflammatory or atherogenic stimuli. This humanized animal model will be useful for investigating the function of human thrombomodulin under pathophysiological conditions in vivo.
Cardiovascular System Cardiology. Vascular system Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Atherosclerosis (general aspects, experimental research) Pharmacology. Drug treatments Biological and medical sciences Medical sciences Vasodilator agents. Cerebral vasodilators Blood and lymphatic vessels

Details

Metrics

Logo image